(NP (NP (NNS Effects)) (PP (IN of) (NP-COOD (NP (NN IL-10)) (CC and) (NP (NN IL-4)))) (PP (IN on) (NP (NP (NP (JJ LPS-induced) (NN transcription) (NNS factors)) (PRN (-LRB- -LRB-) (NP-COOD (NP (NN AP-1)) (, ,) (NP (NN NF-IL6)) (CC and) (NP (NN NF-kappa) (NN B))) (-RRB- -RRB-))) (SBAR (WHNP-49 (WDT which)) (S (NP-SBJ-50 (-NONE- *T*-49)) (VP (VBP are) (VP (VBN involved) (NP (-NONE- *-50)) (PP (IN in) (NP (NN IL-6) (NN regulation))))))))) (. .))
(S (NP-SBJ-51 (NP (NN Interleukin-10)) (PRN (-LRB- -LRB-) (NP (NN IL-10)) (-RRB- -RRB-))) (, ,) (PP-TPC-102 (IN like) (NP (NN IL-4))) (, ,) (VP (VBZ is) (VP (VBN known) (S (NP-SBJ (-NONE- *-51)) (VP (TO to) (VP (VB inhibit) (NP (NP (NN cytokine) (NN expression)) (PP (IN in) (NP (VBN activated) (JJ human) (NNS monocytes)))) (PP (-NONE- *T*-102))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-COOD-52 (CC both) (NP (NN IL-10)) (CC and) (NP (NN IL-4))) (VP (VBP inhibit) (NP (JJ LPS-induced) (NN IL-6) (NP-COOD (NP (NN mRNA)) (CC and) (NP (NN protein))) (NN expression)) (PP (IN by) (S (NP-SBJ (-NONE- *-52)) (VP (VBG inhibiting) (NP (NP (DT the) (NN transcription) (NN rate)) (PP (IN of) (NP (DT the) (NN IL-6) (NN gene))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ strong) (NN inhibition)) (PP (IN of) (NP (DT the) (NN IL-6) (NN transcription) (NN rate)))) (VP (VBD prompted) (S (NP-SBJ (PRP us)) (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP-COOD (NP (NN IL-10)) (CC and) (NP (NN IL-4)))) (PP (IN on) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN transcription) (NNS factors)))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD questioned) (SBAR (IN whether) (CC or) (RB not) (S (NP-SBJ-COOD (NP (NN IL-10)) (CC and) (NP (NN IL-4))) (VP (VBD affected) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NP (NP (NN transcription) (NNS factors)) (SBAR (WHNP-53 (WDT that)) (S (NP-SBJ-54 (-NONE- *T*-53)) (VP (VBP are) (VP (VBN known) (S (NP-SBJ-55 (-NONE- *-54)) (VP (TO to) (VP (VB be) (VP (VBN involved) (NP (-NONE- *-55)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (DT the) (NN IL-6) (NN transcription) (NN rate)))))))))))))) (, ,) (RB namely) (NP-COOD (NP (NP (NN activator) (NN protein-1)) (PRN (-LRB- -LRB-) (NP (NN AP-1)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ nuclear) (NN factor) (NN IL-6)) (PRN (-LRB- -LRB-) (NP (NN NF-IL6)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ nuclear) (NN factor) (NN kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-))))))))))) (. .))
(S (PP (IN In) (NP (NP (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)) (PRN (-LRB- -LRB-) (NP (NNS EMSAs)) (-RRB- -RRB-)))) (NP-SBJ (PRP we)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ-COOD (NP (NN IL-10)) (CC and) (NP (NN IL-4))) (VP (VBD inhibited) (NP (JJ LPS-induced) (NN AP-1) (NN binding) (NN activity)))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ inhibiting) (NN effect)) (PP (IN of) (NP (NN IL-4)))) (VP (VBD was) (ADJP-PRD (ADJP (ADVP (RB slightly) (RBR more)) (JJ pronounced)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NN IL-10))))))) (. .))
(S (NP-SBJ-56 (NP (NN Downregulation)) (PP (IN of) (NP (JJ LPS-induced) (NN AP-1)))) (VP (VBD was) (VP (VP-COOD (VP (VBN accompanied) (NP (-NONE- *-56)) (PP (-NONE- *RNR*-58))) (, ,) (CC and) (RB thus) (VP (ADVP (RB possibly)) (VBN explained) (NP (-NONE- *-56)) (PP (-NONE- *RNR*-58)))) (, ,) (PP-58 (IN by) (NP-LGS (NP (DT a) (VBN reduced) (NN expression)) (PP (IN at) (NP (NN mRNA) (NN level))) (PP (IN of) (NP (NP (NP (DT the) (CD two) (JJ major) (NNS components)) (PP (IN of) (NP (DT the) (NN AP-1) (NN complex)))) (, ,) (RB namely) (NP (NP-COOD (NP (NN c-fos)) (CC and) (NP (NN c-jun))) (SBAR (IN as) (S (NP-SBJ-59 (-NONE- *)) (VP (VBN determined) (NP (-NONE- *-59)) (PP (IN by) (NP (NN Northern) (NNS experiments))))))))))))) (. .))
(S-COOD (S (NP-SBJ-60 (NP (NN Binding) (NN activity)) (PP (IN of) (NP (NN NF-IL6)))) (VP (VBD was) (ADVP (RB also)) (VP (ADVP (RB strongly)) (VBN inhibited) (NP (-NONE- *-60)) (PP (IN by) (NP-LGS (NN IL-4)))))) (IN whereas) (S (NP-SBJ (NN IL-10)) (VP (VBD showed) (NP (DT no) (NN effect)))) (. .))
(S (NP-SBJ-61 (NN NF-IL6) (NN mRNA) (NNS levels)) (VP (VBD were) (RB not) (VP (VBN affected) (NP (-NONE- *-61)) (PP (IN by) (NP-LGS-COOD (NP (NN IL-10)) (CC or) (NP (NN IL-4)))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG suggesting) (SBAR (IN that) (S (NP-SBJ (NN IL-4)) (VP (VBZ affects) (NP (NP (NN binding) (NN activity)) (PP (IN of) (NP (VBG preexisting) (NN NF-IL6))))))))))) (. .))
(S (NP-SBJ-COOD (CC Neither) (NP (NN IL-10)) (CC nor) (NP (NN IL-4))) (VP (VBD inhibited) (NP (JJ LPS-induced) (NN NF-kappa) (NN B) (NN binding) (NN activity))) (. .))
(S (PP (IN In) (NN agreement) (IN with) (NP (DT this) (NN finding))) (, ,) (NP-SBJ (NP (NN Northern) (NNS experiments)) (SBAR (WHADVP-63 (WRB where)) (S (NP-SBJ-64 (NP-COOD (NP (NN p65)) (CC and) (NP (NN p105))) (NN mRNA) (NNS levels)) (VP (VBD were) (VP (VBN determined) (NP (-NONE- *-64)) (ADVP (-NONE- *T*-63))))))) (, ,) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-65 (NP (NN expression)) (PP (IN of) (NP (NP (DT these) (NNS components)) (PP (IN of) (NP (DT the) (NN NF-kappa) (NN B) (NN transcription) (NN factor)))))) (VP (VBD were) (RB not) (VP (VBN affected) (NP (-NONE- *-65)) (PP (IN by) (NP-LGS-COOD (NP (NN IL-10)) (CC or) (NP (NN IL-4))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-COOD (CC neither) (NP (NN IL-10)) (CC nor) (NP (NN IL-4))) (VP (VBD showed) (NP (NP (DT any) (NN effect)) (PP (IN on) (NP (NN I-kappa) (NN B) (NN mRNA) (NN expression)))) (SBAR (IN as) (S (NP-SBJ-66 (-NONE- *)) (VP (VBN determined) (NP (-NONE- *-66)) (PP (IN by) (NP (NN Northern) (NNS experiments))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP-SBJ-COOD (NP (NN IL-10)) (CC and) (NP (NN IL-4))) (ADVP (RB similarly)) (VP (VBP affect) (NP (NN IL-6) (NN expression))) (. .))
(S (ADVP (RB However)) (, ,) (PP (IN for) (NP (NN IL-4))) (NP-SBJ-67 (DT this)) (VP (VBD was) (VP (VBN accompanied) (NP (-NONE- *-67)) (PP (IN with) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NP-COOD (NP (NN AP-1)) (CC and) (NP (NN NF-IL6))) (NN binding) (NN activity))))) (SBAR (IN whereas) (S (NP-SBJ (NN IL-10)) (ADVP (RB only)) (VP (VBD inhibited) (NP (NN AP-1) (NN binding) (NN activity))))))) (. .))
